The pathogenesis of influenza in humans

Reviews in Medical Virology

Volumn 11, Issue 4, 2001, Pages 227-241

  Zambon, Maria C ^a  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FURIN; GLYCOPROTEIN; HEMAGGLUTININ; PROTEINASE; SIALIDASE;

AMINO ACID SEQUENCE; ENZYME ACTIVATION; ENZYME BINDING; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; PATHOGENESIS; PROTEIN DEGRADATION; REVIEW; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

ANIMALS; ANTIGENIC VARIATION; BIRDS; DISEASE RESERVOIRS; EVOLUTION, MOLECULAR; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA, HUMAN; NEURAMINIDASE; ORTHOMYXOVIRIDAE;

EID: 0034898158     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.319     Document Type: Review

References (88)

1. The virus genome and its replication
2. Isolation of influenza C virus from pigs and experimental infection of pigs with influenza C virus
3. Influenza B in seals
4. Population estimates of persons presenting to general practitioners with influenza-like illness, 1987-1996
5. Acute respiratory illness in the community. Frequency of illness and the agents involved
6. Characterization of a novel influenza hemagglutinin, H15: Criteria for determination of influenza A subtypes
7. Evolution and ecology of influenza A viruses
8. Structural basis of immune recognition of influenza virus hemagglutinin
9. The molecular epidemiology of influenza viruses
10. Comparative analysis of evolutionary mechanisms of the hemagglutinin and three internal protein genes of influenza B virus: Multiple cocirculating lineages and frequent reassortment of the NP, M, and NS genes
11. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus
12. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus
13. Intestinal influenza: Replication and characterization of influenza viruses in ducks
14. The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses
15. European swine virus as a possible source for the next influenza pandemic?
16. Characterization of a new avian-like influenza A virus from horses in China
17. Differing virulence of H1N1 and H3N2 influenza strains
18. Isolation of type B influenza virus from the blood of children
19. Detection of influenza virus RNA in peripheral blood mononuclear cells of influenza patients
20. Use of the polymerase chain reaction for demonstration of influenza virus dissemination in children
21. Transplacental transfer of influenza virus
22. PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis
23. Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong
24. Mechanisms involved in natural and experimental neuropathogenicity of influenza viruses: Evidence and speculation
25. Influenza A pandemics of the 20th century with special reference to 1918: Virology, pathology and epidemiology
26. Guillain-Barre syndrome: The swine influenza virus vaccine incident in the United States of America, 1976-77: Preliminary communication
27. Are known pyrogenic cytokines responsible for fever in influenza?
28. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense
29. Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus
30. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics
31. Host cell proteases controlling virus pathogenicity
32. Role of hemagglutinin cleavage for the pathogenicity of influenza virus
33. Receptor determinants of human and animal influenza virus isolates: Differences in receptor specificity of the H3 hemagglutinin based on species of origin
34. Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity
35. Receptor specificity of influenza A viruses from sea mammals correlates with lung oligosaccharides in these animals
36. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential
37. Sialic acid species as a determinant of the host range of influenza A viruses
38. The role of influenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction
39. Changes in H3 influenza A virus receptor specificity during replication in humans
40. Molecular mechanisms of serum resistance of human influenza H3N2 virus and their involvement in virus adaptation in a new host
41. The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses
42. Proteolytic cleavage of influenza virus hemagglutinins: Primary structure of the connecting peptide between HA1 and HA2 determines proteolytic cleavability and pathogenicity of avian influenza viruses
43. Molecular analyses of the hemagglutinin genes of H5 influenza viruses: Origin of a virulent turkey strain
44. Different hemagglutinin cleavage site variants of H7N7 in an influenza outbreak in chickens in Leipzig, Germany
45. Virulence-associated sequence duplication at the hemagglutinin cleavage site of avian influenza viruses
46. The polyadenylation signal of influenza virus RNA involves a stretch of uridines followed by the RNA duplex of the panhandle structure
47. Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin?
48. Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence
49. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties
50. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease
51. Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses
52. Proteolytic cleavage by plasmin of the HA polypeptide of influenza virus: Host cell activation of serum plasminogen
53. An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo
54. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein
55. Expression of influenza B virus haemagglutinin containing multibasic residue cleavage sites
56. Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity
57. Interactions between bacteria and influenza A virus in the development of influenza pneumonia
58. Influenza viruses, cell enzymes, and pathogenicity
59. Initial genetic characterisation of the 1918 Spanish influenza virus
60. Origin and evolution of the 1918 'Spanish' influenza virus haemagglutinin
61. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans
62. The N2 neuraminidase of human influenza virus has acquired a substrate specificity complementary to the hemagglutinin receptor specificity
63. Amino acid residues contributing to the substrate specificity of the influenza A virus neuraminidase
64. Monitoring of viral susceptibility: New challenges with the development of influenza NA inhibitors
65. Genetic variation in neuraminidase genes of influenza A (H3N2) viruses
66. Replication of influenza virus in a continuous cell line: High yield of infective virus from cells inoculated at high multiplicity
67. A novel mechanism for the acquisition of virulence by a human influenza A virus
68. Characterisation of the 1918 'Spanish' influenza virus neuraminidase gene
69. Biologic importance of neuraminidase stalk length in influenza A virus
70. Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wildtype human influenza A virus for squirrel monkeys and adult human volunteers
71. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range
72. Molecular characterization of H9N2 influenza viruses: Were they the donors of the 'internal' genes of H5N1 viruses in Hong Kong?
73. Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus
74. Genetic analysis of the compatibility between polymerase proteins from human and avian strains of influenza A viruses
75. A 36 nucleotide deletion mutation in the coding region of the NS1 gene of an influenza A virus RNA segment 8 specifies a temperaturedependent host range phenotype
76. The role of interferon in influenza virus tissue tropism
77. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems
78. Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans
79. Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus
80. Fusion glycoprotein of human parainfluenza virus type 3: Nucleotide sequence of the gene, direct identification of the cleavage-activation site, and comparison with other paramyxoviruses
81. Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus
82. Nucleotide sequence of yellow fever virus: Implications for flavivirus gene expression and evolution
83. Nucleotide sequence of the 26S mRNA of Sindbis virus and deduced sequence of the encoded virus structural proteins
84. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus
85. Nucleotide sequence of Rous sarcoma virus
86. Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage
87. Identification and structure of the gene encoding gpII, a major glycoprotein of varicella-zoster virus
88. Epstein-Barr virus genome may encode a protein showing significant amino acid and predicted secondary structure homology with glycoprotein B of herpes simplex virus 1